FDA Import Refusal SCS-1352161-4/11/1 — GLAXO SMITHKLINE
The FDA refused shipment SCS-1352161-4/11/1 from GLAXO SMITHKLINE (Canada) on Aug 17, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 17, 2020
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 66VSC99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280